Intrinsic Value of S&P & Nasdaq Contact Us

Axonics, Inc. AXNX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$71.00
+0%

Stock Statistics — AXNX

Axonics, Inc. (AXNX) has a market capitalization of $3.63B and trades at $70.98.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -591.5, Earnings Per Share (EPS) of $-0.12, annual revenue of $366.38M.

The stock has a beta of 0.83, operates in the Healthcare sector.

Trading Data
Current Price$70.98
Market Cap$3.63B
Beta (1Y)0.83
Company
IPO Date2018-10-31
Employees797
CEORaymond W. Cohen
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS05465P1012
CUSIP05465P101
Income (Latest Year)
Revenue$366.38M
Gross Profit$274.55M
EBITDA$7.78M
Operating Income$-26.06M
Net Income$-6.09M
EPS$-0.12
EPS Diluted$-0.12
Shares Outstanding$49.08M
Balance Sheet (Latest Year)
Total Assets$719.92M
Current Assets$491.42M
Cash & ST Investments$344.96M
Total Liabilities$82.36M
Total Debt$27.62M
Net Debt$-77.19M
Total Equity$637.56M
Debt / Equity0.04
Valuation Ratios
P/E Ratio-591.5
P/S Ratio9.9
P/B Ratio5.69
EV/EBITDA (approx)466.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message